Skip to main content
Biomolecules and Biomedicine logoLink to Biomolecules and Biomedicine
letter
. 2024 Apr 1;24(2):434–435. doi: 10.17305/bb.2023.10233

Citation metrics and scientometrics

Rajko Igić 1,2
PMCID: PMC10950349  PMID: 38197799

I read the article “Scientometrics and academia” by Dr. Zerem and colleagues [1]. My perspective on citation metrics and scientometrics is more cautious. Therefore, in this article, I present my viewpoint on this subject.

Humans have always needed to count in their daily life. For this, they likely first used fingers and tally marks. The long-term use of numbers led to gradual improvements. The early numeral system, the base 60 or sexagesimal system, was developed by the Sumerians, adopted by the Babylonians, and is still used for measuring time, angles, and geographic coordinates. In the 12th century CE, the decimal or Hindu-Arabic number system was introduced to the West. Our tendency to count seems inherent; at times, it appears to border on arithmomania. With the advent of computing technology, counting became enormously easy, leading to new applications such as citation metrics or citatometry.

In 1955, Eugene Garfield conceived a new method for cataloging scientific literature, and in 1964, he established the Institute for Scientific Information (ISI) in Philadelphia [2]. This method of indexing disseminated scientific literature globally, and citatometry became the foundation for scientometrics, a quantitative study of science that evaluates publications and the scientific contributions of individual researchers, research groups, institutions, journals, and the science development in a country. Today, Clarivate Analytics continues to use this tool to spread scientific information.

Citatometry is based on the number of citations a work receives; more citations indicate a greater impact. Citation data can be obtained from specific databases and, more recently, from various alternative metrics like reviews, downloads, impact on health, and environmental benefits. However, questions about the reliability of using citation frequency as a measure of scientific progress persist. These concerns have been debated, and the limitations relate to the impact of a work or its quality [3]. For instance, biochemist Olive H. Lowry’s method for protein determination has been cited 305,148 times, far exceeding the total citations of any Nobel Prize winner [4]. In contrast, Albert Einstein’s works were cited 1,564 times during his lifetime (until 1955), and discoveries like those of Milutin Milanković received “delayed recognition” during his lifetime [5]. Conversely, a lower-quality article might be cited to correct problematic data or opinions. Among the 7,125 highly cited scientists (1 among 1,000), many “position papers” exist, where all listed authors (e.g., 50, 100, 1,000) receive the same number of citations as the article, but only a few authors contribute [6]. In such multi-author papers, the number of self-citations is proportional to the number of authors.

Such inconsistencies in citatometry should be addressed. One solution is to present citation metrics separately for publications and authors. The authors should share the citations of the paper. This adjusted citation number, iC, would lead to a fairer distribution and eliminate so-called highly cited scientists who benefit at the expense of others. This approach would greatly assist scientometrics [7].

Despite citatometry’s shortcomings, scientometrics should not be abandoned as it provides short-term predictability of scientific impact [8]. Caution is necessary when using only citatometry to evaluate research publications [9]. Alternative metrics may help. Caution is particularly warranted in research institutions, funding agencies, and academia [1]. Ideally, evaluating scientific impact would involve reading each publication and determining its significance. However, the Web of Science tracks over 9,000 journals, and there are many more “lesser” journals not included in this database. It is impractical to find enough evaluators to read over a million papers annually, unless, perhaps, one day, wise robots will do so. Until then, classic methods of estimation often take 30, 60, or more years to recognize the most significant innovations and contributions to progress.

Let me illustrate with an example of how classic research assessment begins. When Professor U.S. von Euler visited the University of Tuzla in 1982 [10], I presented our publications on ACE activity in various eye structures [11–14]. He remarked, “I am familiar with these studies. ACE is crucial to the renin-angiotensin system, essential for cardiovascular and renal functions. When blood pressure falls, the kidneys release renin, forming angiotensin II, one of the most potent vasoactive substances, causing vasoconstriction and a rise in blood pressure. ACE in eye tissues suggests local angiotensin II production, regulating blood flow, including in the retina. Therefore, using ACE inhibitors in millions of hypertensive patients could benefit various eye diseases. This is an important discovery.” In 1996, Van Haeringen noted, “Ophthalmic literature on the RAS began in 1977 with a study by Igić and colleagues on detecting ACE activity in retina homogenates,” and in 2016, Choudhary et al. published a comprehensive literature survey on the RAS in the eye, retrieving 180 publications since 1977 [15, 16]. This reflects high interest in the subject and supports von Euler’s opinion. However, our publications on ACE and renin in the eye, from 1975 to the present, have only garnered 135 citations, far fewer than the several thousand citations an assistant reviewer might receive for contributing to a “position paper”. This raises the question of how citatometry can assist in the final evaluation of this and other discoveries.

Science is a collective endeavor of researchers across various fields, aiming to form theories and concepts through experimentation and observation, revealing nature’s secrets. The exponential increase in scientific literature does not always proportionally offer new directions or stimulate knowledge expansion [17].

In conclusion, to evaluate the value of research publications, classic assessment methods are needed in addition to citations and alternative metrics. However, as this approach is subjective, the final evaluation often comes after several generations of scientists have made their contributions. It is uncertain if the development of artificial intelligence will provide a fast and competent additional evaluation of every publication.

Footnotes

Conflicts of interest: Author declares no conflicts of interest.

References

  • 1.Zerem E, Vranić S, Hanjalić K, Milošević DB. Scientometrics and academia. Biomol Biomed. 2023 doi: 10.17305/bb.2023.10173. https://doi.org/10.17305/bb.2023.10173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Garfield E. Citation indexes to science: a new dimension in documentation through association of ideas. Science. 1955;122:108–11. doi: 10.1126/science.122.3159.108. https://doi.org/10.1126/science.122.3159.108. [DOI] [PubMed] [Google Scholar]
  • 3.Aksnes DW, Langfeldt L, Wouters P. Citations, citation indicators, and research quality: an overview of basic concepts and theories. SAGE Open. 2019;9:1–17. https://doi.org/10.1177/2158244019829575. [Google Scholar]
  • 4.Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193(1):265–75. [Internet] Available from: https://www.jbc.org/article/S0021-9258(19)52451-6/pdf [Accessed 02 January 2024]. [PubMed] [Google Scholar]
  • 5.Igić R. Citations of scientific publications as a measure of impact. Medici.com. 2023 Dec;20:63–4. [Google Scholar]
  • 6.Zerem E. The ranking of scientists based on scientific publications assessment. J Biomed Inform. 2017;75:107–9. doi: 10.1016/j.jbi.2017.10.007. https://doi.org/10.1016/j. [DOI] [PubMed] [Google Scholar]
  • 7.Igić R. Citatometry is in crisis, corrected number of citations (iC) is a life vest. Clin Case Rep Stud, BioRes Scientia Publ. 2023;3(6):1–2. https://doi.org/10.59657/2837-2565.brs.23.093. [Google Scholar]
  • 8.Wang Ds, Song C, Barbasi A-L. Quantifying long-term scientific impact. Science. 2013;342(6154):127–32. doi: 10.1126/science.1237825. https://doi.org/1sss0.1126/science.12378. [DOI] [PubMed] [Google Scholar]
  • 9.Hirsch JE. An index to quantify an individual’s scientific research output. Proc Natl Acad Sci USA. 2005;102(46):16569–72. doi: 10.1073/pnas.0507655102. https://doi.org/10.1073/pnas.0507655102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Igić R. Remembrances of Ulf Svante von Euler. Acta Physiol (Oxf) 2018;224(3):e13098. doi: 10.1111/apha.13098. https://doi.org/10.1111/apha.13098. [DOI] [PubMed] [Google Scholar]
  • 11.Igić R, Robinson CJG, Erdös EG. Angiotensin I converting enzyme in the choroid plexus and in the retina. Sixth Int Congr Pharmacol Helsinki, 1975, Abstract 408.
  • 12.Igić R, Robinson CJ, Milosević Z, Wilson CM, Erdös EG. Aktivnost renina i enzima konvertora angiotenzina u retini i cilijarnom telu [Activity of renin and angiotensin I converting enzyme in retina and ciliary body (author’s transl)] Lijec Vjesn. 1977;99(8):482–84. https://pubmed.ncbi.nlm.nih.gov/199819/. [PubMed] [Google Scholar]
  • 13.Ward PE, Stewart TA, Hammon KJ, Reynolds RC, Igić RP. Angiotensin I converting enzyme (kininase II) in isolated retinal microvessels. Life Sci. 1979;24(15):1419–23. doi: 10.1016/0024-3205(79)90013-4. https://doi.org/10.1016/0024-3205(79)90013-4. [DOI] [PubMed] [Google Scholar]
  • 14.Igić R, Kojović V. Angiotensin I converting enzyme (kininase II) in ocular tissues. Exp Eye Res. 1980;30(3):299–303. doi: 10.1016/0014-4835(80)90010-x. https://doi.org/10.1016/0014-4835(80)90010-x. [DOI] [PubMed] [Google Scholar]
  • 15.Van Haeringen NJ. The renin-angiotensin system in the human eye. Br J Ophthalmol. 1996;80:99–100. doi: 10.1136/bjo.80.2.99. [Internet] Available from: [Accessed 02 January 2024] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Choudhary R, Kapoor MS, Singh A, Bodakhe SH. Therapeutic targets of renin-angiotensin system in ocular disorders. J Curr Ophthalmol. 2016;20(29):7–16. doi: 10.1016/j.joco.2016.09.009. https://doi.org/10.1016/j.joco.2016.09.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Igić R. The influence of the civil war in Yugoslavia on publishing in peer-reviewed journals. Scientometrics. 2002;53:447–52. https://doi.org/10.1023/A:1014833315145. [Google Scholar]

Articles from Biomolecules and Biomedicine are provided here courtesy of Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina

RESOURCES